<code id='95870512C3'></code><style id='95870512C3'></style>
    • <acronym id='95870512C3'></acronym>
      <center id='95870512C3'><center id='95870512C3'><tfoot id='95870512C3'></tfoot></center><abbr id='95870512C3'><dir id='95870512C3'><tfoot id='95870512C3'></tfoot><noframes id='95870512C3'>

    • <optgroup id='95870512C3'><strike id='95870512C3'><sup id='95870512C3'></sup></strike><code id='95870512C3'></code></optgroup>
        1. <b id='95870512C3'><label id='95870512C3'><select id='95870512C3'><dt id='95870512C3'><span id='95870512C3'></span></dt></select></label></b><u id='95870512C3'></u>
          <i id='95870512C3'><strike id='95870512C3'><tt id='95870512C3'><pre id='95870512C3'></pre></tt></strike></i>

          
          WSS
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          fashion